Social Media Influencers Fueling Unofficial Trade for Unlicensed Slimming Drug
A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers market the substance there before redirecting customers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Express Worries
However, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of uncertain source.
Some experts stated the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Elimination
According to TikTok, the platform has taken down problematic material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform safe and investing in strengthening compliance measures.
Digital Trading Activities
Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, glowing reviews and detailed guides for preparing or injecting at residence.
After minutes of joining one community, a vendor posted contact information, where most purchases occur. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Item Information and Costs
Inside these groups, messages display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram said it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to potentially serious medical dangers”.
